Year: 2022

CALGARY, Alberta, Nov. 15, 2022 (GLOBE NEWSWIRE) — Peyto Exploration & Development Corp. (TSX: PEY) (“Peyto”) confirms that the monthly dividend with respect to November 2022 of $0.05 per common share is to be paid on December 15, 2022, for shareholders of record on November 30, 2022. The ex-dividend date for the November dividend is November 29, 2022. Starting January 2023, the monthly dividend will increase to $0.11 per common share and is to be paid on February 15, 2023, for shareholders of record on January 31, 2023. The ex-dividend date for the January dividend is January 30, 2023. Dividends paid by Peyto to Canadian residents are eligible dividends for Canadian income tax purposes. Shareholders and interested investors are encouraged to visit the Peyto website at www.peyto.com to learn more about what makes...

Figure 1 Cariboo Gold Project Deposits LocationFigure 2 Lowhee Zone 2022 Drill HighlightsFigure 3 Lowhee Proposed Bulk Sample Infill Drilling HighlightsFigure 4 Images of portal to Lowhee Zone on Barkerville MountainFigure 5 Infographic of Ore Sorting Preconcentration ProcessMONTREAL, Nov. 15, 2022 (GLOBE NEWSWIRE) — Osisko Development Corporation (“Osisko Development” or the “Company“) is pleased to announce drilling results from the 2022 exploration and category conversion drill campaign at its 100%-owned Cariboo Gold Project (“Cariboo“), located in central British Columbia. ACTIVITIES SUMMARY:6,500 meters of total infill drilling conducted in 2022 at the Lowhee Zone within Cariboo. 27 holes drilled at the Lowhee Zone at closely spaced 12.5 meter intervals within the area proposed...

Science 37 is recognized for its unified platform to enable more patient-centric trials RESEARCH TRIANGLE PARK, N.C., Nov. 15, 2022 (GLOBE NEWSWIRE) — Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, was named as winner in the Telehealth Innovation category at the University of California San Francisco (UCSF) Health Hub Digital Health Awards, at the 2022 HLTH conference. Science 37’s tech-enabled virtual site, known as a Metasite, leverages telemedicine to execute tech-enabled clinical trials that are faster, more inclusive, and patient-centric. Built on a unified platform, telehealth allows investigators to oversee the administration of treatments or procedures by mobile nurses—regardless of the patient’s location. The telemedicine functionality supports seamless data capture, ensuring safety and...

Greenville, South Carolina, Nov. 15, 2022 (GLOBE NEWSWIRE) — ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) a leading US-based franchise system providing drug testing, alcohol screening, DNA and clinical lab testing services announced today that it expects to release financial results for the third quarter of 2022 before the market open Monday, November 28, 2022. The Company will host a conference call on Monday November 28, 2022 at 12:00 pm Eastern Time to review the results for the Q3 interim period, provide an operational update and discuss recent milestones. The dial-in number for the conference call is as follows: Canada / USA Toll Free         1-800-319-4610  International Toll                  1-604-638-5340 Callers should dial in 5 – 10 min prior to the scheduled start time and ask to join the ARCpoint call. ARCpoint’s...

MONTERREY, Mexico, Nov. 15, 2022 (GLOBE NEWSWIRE) — Fomento Económico Mexicano, S.A.B. de C.V. (“FEMSA” or the “Company”) (NYSE: FMX; BMV: FEMSAUBD, FEMSAUB) announced the placement of Mexican Peso-denominated sustainability linked bonds in the Mexican market for a total of Ps. 9,273,843,400.00. The issued bonds were purchased by 33 institutional investors and the issuance was oversubscribed 1.9x times. The transaction was completed through a dual-tranche format with the tickers FEMSA 22-2L and FEMSA 22L. The first tranche was issued at an annual fixed rate of 9.65% (Mbono+0.45%) for an amount of Ps. 8,446,384,600.00 due in 2032. The second tranche was issued at an annual variable rate of TIIE28 + 0.10% for an amount of Ps. 827,458,800.00 due in 2027 (the “Bonds”). Pursuant to the terms of the Bonds, they are linked to FEMSA’s...

2022 AGM to be Held on December 19, 2022 TORONTO, Nov. 15, 2022 (GLOBE NEWSWIRE) — Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: NXTTF), a health-tech company that leverages advancements in science and technology to build breakthrough companies that transform human wellness, will host its Annual General Meeting of Shareholders in-person on Monday December 19, 2022 at 9:30 a.m. ET in the Ballroom Trillium A at the Hilton Garden Inn Toronto Airport, 3311 Caroga Drive, Mississauga, Ontario L4V 1A3 (the “AGM”). Meni Morim, CEO of Lifeist, will discuss the Company’s performance and provide a general corporate update followed by a live question and answer session. If any registered shareholder or valid proxyholder plans to attend the AGM in person, they are asked to please confirm their attendance...

CONCORD, Calif., Nov. 15, 2022 (GLOBE NEWSWIRE) — AssetMark Financial Holdings, Inc, a leading wealth management platform for financial advisors, today underscored its commitment to environmental, social and governance (ESG) practices in announcing it has entered into a sustainability linked financing agreement. The deal is an amendment to the previously announced credit facility commitment, converting AssetMark’s $500 million corporate revolving credit facility into a Sustainability-Linked Loan. The arrangement introduces a margin adjustment incentive mechanism tied to three of the firm’s Sustainability Accounting Standards Board-aligned ESG objectives:Increasing the proportion of diverse new hires; Providing ESG training to advisors using its platform; and Expanding the number of ESG investment strategists offered on the AssetMark...

PARIS and CAMBRIDGE, Mass., Nov. 15, 2022 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced that Laurent Levy, co-founder and chairman of the executive board, and Bart Van Rhijn, chief financial officer, will participate in a virtual fireside chat at the 5th annual Evercore ISI HealthCONx Conference on Thursday, December 1, 2022, at 9:15 AM ET / 3:15 PM CET. The fireside chat will be webcast live from the events page of the Investors section of the Company’s website. A replay of the webcast will be archived and available for 90 days following the event. About NANOBIOTIX Nanobiotix is a late-stage clinical biotechnology company pioneering disruptive,...